Summary
Drug overdose is a common occurrence which accounts for up to 25 % of medical inpatient admissions. Intentional overdose or attempted suicide is the most common cause of overdose, but there are other types of overdose which are often unrecognised as are the effects caused by these overdoses. Iatrogenic overdose occurs frequently and is often unavoidable. Many patients will make mistakes with their treatment and unwittingly suffer from the toxic effects of the drugs they are taking. About 7% of intentional overdose patients who are admitted to hospital have taken the drug for some psychological effect they have been seeking and have taken too much. This group is described as those who take ‘drugs for kicks’.
As many of the drugs taken cross the blood-brain barrier and exert some toxic effect on the cerebral cortex, secondary psychological disturbances frequently occur in all of these groups of patients, and can sometimes be the only sign of dangerous toxicity. It is important to recognise the patient’s gross disturbances of behaviour, thinking and perception as a manifestation of drug toxicity which can be life threatening and often requires intense medical treatment. The range of the psychological response is somewhat limited and there is not a specific psychological disturbance characteristic of the toxicity of each group of drugs. However, there are some reactions which, coupled with the physical symptoms shown by the patient, can help to identify the patient as suffering from the toxic effects of drugs and even give some indication as to the type of drugs taken.
This article describes the various psychiatric syndromes caused by drugs in overdose and attempts to identify these with most of the commonly encountered groups of drugs.
Similar content being viewed by others
References
Agulnik, P.L.; Dimascio, A. and Moore, P.: Acute brain syndrome associated with lithium therapy. American Journal of Psychiatry 129: 133–135 (1972).
Akindele, M.D. and Odejide, A.O.: Amodiaquine-induced involuntary movements. British Medical Journal 2: 214–215 (1976).
Alexander, J.I. and Spence, A.A.: Central-nervous system effects of pentazocine. British Medical Journal 2: 224–225 (1974).
Allen, R. and Young, S.: Phencyclidine-induced psychosis. American Journal of Psychiatry 135: 1081–1084 (1978).
Amdisen, A.: Serum level monitoring and clinical pharmacokinetics of lithium. Clinical Pharmacokinetics 2: 73–92 (1977).
Ananth, J. and Ruskin, R.: Unusual reaction to lithium. Canadian Medical Association Journal III: 1049–1051 (1974).
Angrist, B.M. and Gershon, S.: Psychiatric sequelae of amphetamine use; in Shader (Ed) Psychiatric Complications of Medical Drugs (Raven Press, New York 1972).
Ashton, M.G.; Ball, S.G.; Thomas, T.H. and Lee, M.R.: Water intoxication associated with carbamazepine treatment. British Medical Journal 1: 1134–1135 (1977).
Ayd, F.J.: Renal function and renal pathology in patients with lithium-induced impairment of renal concentrating ability. International Drug Therapy Newsletter 13: 4 (1978).
Azarnoff, D.L.: Application of metabolic data to the evaluation of drugs. Journal of the American Medical Association 211: 1691 (1970).
Baer, L.; Glassman, A.H. and Kassir, S.: Negative sodium balance in lithium carbonate toxicity. Archives of General Psychiatry 29: 823–827 (1973).
Baker, J.P. and Farley, J.D.: Toxic psychosis following atropine eye-drops. British Medical Journal 2: 1390 (1958).
Baloch, N.: Steroid psychosis: A case report. British Journal of Psychiatry 124: 545 (1974).
Barter, B. and Roberts, R.J.: Unusual case of aminophylline intoxication. Pediatrics 52: 608–609 (1973).
Beamish, P. and Kilon, L.G.: Psychosis due to amphetamine consumption. Journal of Mental Science 106: 337–343 (1960).
Behrman, S.: Mutism induced by phenothiazines. British Journal of Psychiatry 121: 599–604 (1972).
Bethell, M.F.: Toxic psychosis caused by “Preludin”. British Medical Journal 1: 30–31 (1957).
Biggs, J.T.; Spiker, D.G.; Petit, J.M. and Ziegler, V.E.: Tricyclic antidepressant overdose. Journal of the American Medical Association 238: 135–138 (1977).
Birtchnell, J. and Alarcon, J.: Depression and attempted suicide. British Journal of Psychiatry 118: 289–296 (1971).
Black, D. and Woollacott, S.: Acute toxic psychosis in two children treated with Benzhexol Hydrochloride (Artane). British Journal of Psychiatry 125: 483 (1974).
Boba, A. and Peart, K.A.: Propranolol in attempted suicide. Illinois Medical Journal 151: 181–182 (1977).
Bonhoffer, K.: Die Psychosen im Ge folge von akuten Infektionen, allgemeinerkrankungen und inneren erkrankungen; in Asschaffenburg, G. (Ed.) Handbuch der Psychiatrie (Leipzig und wien Deuticke, 1912).
Borda, I.T.; Slone, D. and Jick, H.: Assessment of adverse reactions within a drug surveillance programme. Journal of the American Medical Association 205: 645–647 (1968).
Borman, M.C.: Danger with Benadryl of self-medication and large dosage. Journal of the American Medical Association 133: 394 (1947).
Bradberry, J.C. and Owens, J.: Acute psychotic reaction to procaine penicillin. American Journal of Hospital Pharmacy 32: 411 (1975).
Brandon, S.: Unusual effect of fenfluramine. British Medical Journal 4: 557–558 (1969).
Brewer, C.: Suicide with tricyclic antidepressants. British Medical Journal 3: 110 (1976).
Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Mianserin: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 16: 273–301 (1978).
Brogden R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 18: 1–24 (1979).
Burns, R.; Thomas, D.W. and Barron, V.J.: Reversible encephalopathy possibly associated with Bismuth Subgallate ingestion. British Medical Journal 1: 220–223 (1974).
Canal, D.A.: Adverse reactions to nalidixic acid. Lancet 2: 441 (1965).
Cahn, C.H.: Intoxication by ethchlorvynol (Placidyl). Report of four cases. Canadian Medical Association Journal 81: 733–734 (1959).
Calloway, S.P.: Suicide and neuropsychiatric side effects in patients taking niridazole. Medical Journal of Zambia 10: 70 (1976).
Carney, M.W.P.: Five cases of bromism. Lancet 2: 523–524 (1971).
Carney, M.W.P.: Atropine poisoning. British Medical Journal 2: 334 (1974).
Carney, M.W.P.: Paranoid psychosis with indomethacin. British Medical Journal 2: 994–995 (1977).
Carr, A.C. and Hobson, R.P.: High serum concentrations of antidepressants in elderly patients. British Medical Journal 2: 1151 (1977).
Casey, D.E.: Amantadine intoxication reversed by physostigmine. New England Journal of Medicine 9: 298 (1978).
Cass, L.J.; Alexander, L. and Enders, M.: Complications of corticotropin therapy in multiple sclerosis. Journal of the American Medical Association 197: 173 (1966).
Celesia, G.G. and Barr, A.N.: Psychosis and other psychiatric manifestations of levodopa therapy. Archives of Neurology 23: 193 (1970).
Church, G. and Marriott, H.J.L.: Digitalis delirium. Circulation 20: 549 (1959).
Church, G.; Schamroth, L.; Schwartz, N.L. and Marriott, H.J.: Deliberate digitalis intoxication: A comparison of the toxic effects of four glycoside preparations. Annals of Internal Medicine 57: 946 (1962).
Clein, L.: Toxic psychosis caused by “Preludin”: British Medical Journal 1: 282 (1957).
Conell, P.H.: Amphetamine psychosis. Maudsley Monograph No. 5 (Oxford University Press, Oxford 1958).
Crome, P. and Newman, B.: Poisoning with maprotiline and mianserin. British Medical Journal 3: 260 (1977).
Davies, D.M.: Textbook of Adverse Drug Reactions (Oxford University Press, Oxford 1977).
Davies, D.M. and Allaye, R.: Amitriptyline poisoning. Lancet 2: 543 (1963).
Davies, R.K. and Harrow, M.: Confusional episodes and antidepressant medication. American Journal of Psychiatry 128: 95 (1971).
Davis, K.L.; Hollister, L.E. and Berger, P.A.: Baclofen in schizophrenia. Lancet 1: 1245 (1976).
Davison, K.: Drug induced psychoses and their relationship to schizophrenia; in Kemali et al. (Eds) Schizophrenia Today (Pergamon Press, Oxford 1976).
Duncan, H. and Kerr, D.: Toxic psychosis due to isoniazid. British Journal of Diseases of the Chest 56: 131 (1962).
Erikssen, J.: Atropine psychosis. Lancet 1: 53 (1969).
Essig, C.F.: Addiction to non-barbiturate sedative and tranquillising drugs. Clinical Pharmacology and Therapeutics 5: 334 (1964).
Evans, L.: The assessment of self-poisoning — medical and psychiatric aspects: in Pilowsky and Chenoweth (Eds). Psychiatry in the General Hospital, pp.70–74 (Ciba-Geigy, Adelaide 1977).
Evans, L.: A case of lithium poisoning. A cautionary tale. Australian and New Zealand Journal of Psychiatry 12: 2 (1978a).
Evans, L.: Haloperidol and benztropin in rapid neuroleptization. Medical Journal of Australia 1: 567–568 (1978b).
Fahn, S.; Craddock, G. and Kumin, G.: Acute toxic psychosis from suicidal overdosage of amantadine. Archives of Neurology 25: 45–48 (1971).
Fleminger, R.: Visual hallucinations and illusions with propranolol. British Medical Journal 1: 1182 (1978).
Forrest, J.A.H. and Tarala, R.A.: Abuse of drugs “for kicks”: A review of 252 admissions. British Medical Journal 4: 136–139 (1973).
Fraser, H.F.; Isbell, H.; Eisenman, A.J.; Wilkler, A. and Pescor, F.T.: Chronic barbiturate intoxication. Archives of Internal Medicine 94: 34–41 (1954).
Garrison, M.F. and Moffitt, E.M.: Clinical Notes, imipramine hydrochloride intoxication. Journal of the American Medical Association 179: 456–458 (1962).
Gazzard, B.G.; Davis, M.; Spooner, J. and Williams, R.: Why do people use paracetamol for suicide? British Medical Journal 1: 212–213 (1976).
Gershon, S.; Holmberg, G.; Mattson, E.; Mattsson, N. and Marshall, A: Imipramine hydrochloride. Archives of General Psychiatry 6: 96–101 (1962).
Gibson, I.I.J.M.: Barbiturate delirium. Practitioner 197: 345 (1966).
Glaser, G.H.: Psychotic reactions induced by corticotropin (ACTH) and cortisone. Psychosomatic Medicine 15: 280–291 (1953).
Goodman, L.S. and Gilman, A.: The Pharmacological Basis of Therapeutics (MacMillan, New York 1975).
Goodwin, F.K.: Behavioural effects of L-Dopa in man; in Shader, (Ed) Psychiatric Complications of Medical Drugs (Raven Press, New York 1972).
Goolker, P. and Schein, J.: Psychic effects of ACTH and cortisone. Psychosomatic Medicine 15: 589–613 (1953).
Gott, P.H.: Cyclizine toxicity: Intentional abuse of a proprietary antihistamine. New England Journal of Medicine 279: 596 (1968).
Granerus, A.: Factors influencing the occurrence of “on-off” symptoms during long term treatment with L-Dopa. Acta Medica Scandinavica 203: 75–85 (1978).
Grant, R.H.E.: Carbamazepin in the treatment of severe epilepsy; in Birkmayer (Ed) Epileptic Seizures — Behaviour — Pain (Hans Huber, Berne 1976).
Green, S.D.R. and Kendall-Taylor, P.: Heart block in mianserin hydrochloride overdose. British Medical Journal 2: 1190 (1977).
Greenwood, R. and Peachey, R.S.: Acute amphetamine poisoning. An account of 3 cases. British Medical Journal 1: 742–744 (1957).
Greer, H.D.; Ward, H.P. and Corbrin, K.B.: Chronic salicylate intoxication in adults. Journal of the American Medical Association 193: 55 (1965).
Harris, J.T. and Rossiter, M.: Fatal Lomotil poisoning. Lancet 1: 150 (1969).
Harthorne, J.W.; Marcus, A.M. and Kaye, M.: Management of massive imipramine overdosage with mannitol and artificial dialysis. New England Journal of Medicine 268: 33–35 (1963).
Heisterkamp, D.V. and Cohen, P.J.: Effect of intravenous premedication with lorazepam, pentobarbitone or diazepam on recall. British Journal of Anaesthesia 47: 79 (1975).
Henderson, W. and Psaila, A.: Lomotil poisoning. Lancet 1: 307 (1969).
Herrero, F.A.: Lithium carbonate toxicity. Journal of the American Medical Association 226: 1109–1110 (1973).
Hoff, E.C.: Brain syndromes associated with drug or poison intoxication; in Friedman and Kaplan (Eds) Comprehensive Textbook of Psychiatry, pp.759–775 (Williams and Wilkins, Baltimore 1967).
Hoffman, W.H.; Chodoroff, G. and Piggott, L.R.: Haloperidol and thyroid storm. American Journal of Psychiatry 135: 484–486 (1978).
Hollender, M.H.; Jamieson, R.C.; McKee, E.M.A. and Roback, H.B.: Anticholinergic delirium in a case of munchausen syndrome. Am. J. Psychiat. 135: 1407–1409 (1978).
Hollister, L.E.: Complications from psychotherapeutic drugs. Clinical Pharmacology and Therapeutics 5: 322–333 (1964).
Hudson, H.S. and Walker, H.I.: Withdrawal symptoms following ethclorvynol (Placidyl) dependence. American Journal of Psychiatry 118: 361 (1961).
Hurwitz, N. and Wade, O.L.: Intensive hospital monitoring of adverse reactions to drugs. British Medical Journal 1: 531 (1969).
Ing, T.S.; Rann, A.C.; Armbruster, K.F.W.; Ovama, J.H. and Klawans, H.I.: Accumulation of amantadine hydrochloride in renal insufficiency. New England Journal of Medicine 291: 1257 (1974).
Isbell, H.: Addiction to barbiturates and the barbiturate abstinence syndrome. Annals of Internal Medicine 33: 108–121 (1950).
Isbell, H.; Altschul, S.; Kornetsky, C.; Eisenman, A.J.; Flanary, H.G. and Fraser, H.F.: Chronic barbiturate intoxication. An experimental study. Archives of Neurology and Psychiatry 64: 1–28 (1950).
Jackson, S.L.: Psychosis due to isoniazid. British Medical Journal 2: 743–746 (1957).
Janowsky, D.S.: Neurotransmitter and psychostimulant induced psychosis activation. Journal of Psychiatric Research 13: 59–60 (1976).
Johns, M.W.: Self-poisoning with barbiturates in England and Wales during 1959–74. British Medical Journal 1: 1128–1130 (1977).
Johnson, D.A.W.: The psychiatric side-effects of drugs. Practitioner 209: 320–326 (1972).
Jones, I.H.; Stevenson, J.; Jordan, A.; Connell, H.M.; Hetherington, H.D.G. and Gibney, G.N.: Pheniramine as an Hallucinogen. Medical Journal of Australia 1: 382–386 (1973).
Juul-Jensen, P. and Schou, M.: Permanent brain damage after lithium intoxication. British Medical Journal 4: 673 (1973).
Kane, F.J. and Taylor, T.W.: Mania associated with the use of INH and cocaine. American Journal of Psychiatry 119: 1098–1099 (1963).
Katz, S.; Kishore, S.; Gittleman-Klein, R. and Klein, D.F.: Clinical pharmacological management of hyperkinetic children. International Journal of Mental Health 4: 157–181 (1975).
Kayne, R.C.: Acute brain syndrome in an elderly patient. Drug Intelligence. Clinical Pharmacology 8: 476–481 (1974).
King, J.T.: Digitalis delirium: Annals of Internal Medicine 33: 1360 (1950).
Klein, D.F.: Visual hallucinations with imipramine. American Journal of Psychiatry 121: 911–914 (1965).
Klein, D.F. and Fink, M.: Psychiatric reaction patterns to imipramine. American Journal of Psychiatry 119: 432–438 (1962).
Korolenko, C.P.; Yevseyeva, T.A. and Volkov, P.P.: Data for a comparative account of toxic psychoses of various aetiologies. British Journal of Psychiatry 115: 273 (1969).
Kraepelin, E.: Uber die beeinflussung einfacher Psychischer vorgange durch einige Arzneimittel. Jena Gustav Fischer (1892).
Krauthammer, C. and Klerman, G.L.: Secondary mania: Archives of General Psychiatry 35: 1333–1339 (1978).
Lader, M.H.: Anxiolytic drugs. British Journal of Hospital Medicine Jan: 79–82 (1973).
Lake, C.R. and Fann, W.E.: Possible potentiation of haloperidol neurotoxicity in acute hyperthyroidism. British Journal of Psychiatry 123: 523–525 (1973).
Lavin, P. and Alexander, C.P.: Dementia associated with Clonidine therapy. British Medical Journal 1: 628 (1975).
Lawson, A.A.H. and Mitchell, I.: Patients with acute poisoning seen in a general medical unit (1960–71). British Medical Journal 4: 153–156 (1972).
Learoyd, B.M.: Psychotropic drugs and the elderly patient. Medical Journal of Australia 1: 1131 (1972).
Lely, A.H. and van Enter, C.H.J.: Large scale digitoxin intoxication. British Medical Journal 3: 737 (1970).
Lemere, F.: Drug habituation (correspondence). Journal of the American Medical Association 160: 1431 (1956a).
Lemere, F.: Habit forming properties of meprobamate. Archives of Neurology and Psychiatry 76: 205–206 (1956b).
Levi, A.J.; Sherlock, S. and Walker, D.: Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet 1: 1275 (1968).
Levin, M.: Toxic psychoses; in Arieti (Ed) American Handbook of Psychiatry (Basic Books, New York 1959).
Liddell, K.: An unusual case of urticaria — cause and therapy. Current Medical Resources and Operations 3: 386–387 (1975).
Liden, C.B.; Lovejoy, F.H. Jr. and Costello, G.C.: Phencyclidine (Sernylan) poisoning. Journal of Pediatrics 83: 844–845 (1973).
Lipowski, Z.J.: Delirium, clouding of consciousness and confusion. Journal of Neurological and Mental Disorders 145: 227 (1967).
Lipowski, Z.J.: Organic brain syndromes: Overview and classification; in Benson and Blumer (Eds) Psychiatric Aspects of Neurologic Disease (Grune and Stratton, New York 1977).
Lipowski, Z.J.: Organic brain syndromes: a reformulation. Comprehensive Psychiatry 19: 309–322 (1978).
Luby, E.D. and Domino, E.F.: Toxicity from large doses of imipramine and an M.A.O. inhibitor in suicide intent. Journal of the American Medical Association 177: 68–69 (1961).
Luby, E.D. and Domino, E.F.: Additional evidence of the addiction liability of glutethimide in man. Journal of the American Medical Association 181: 46–48 (1962).
Lyon, A.F. and DeGraff, A.C.: The neurotoxic effects of digitalis. American Heart Journal 65: 839–840 (1963).
McClelland, H.A.: Psychiatric complications of drug therapy (part I and II). Adverse Drug Reaction Bulletin 40: 128–131 and 41: 132–135 (1973).
McClelland, H.A.: Psychiatric disorders; in Davies (Ed) Textbook of Adverse Drug Reactions (Oxford University Press, Oxford 1977).
McGennis, A.J.: Lithium carbonate and tetracycline interaction. British Medical Journal 1: 1183 (1978).
McVie, J.G.: Clinical Pharmacology; in Girdwood (Ed) (Bailliere Tindall, London 1976).
Malahy, B.: The effect of instruction and labelling on the number of medication errors made by patients at home. American Journal of Hospital Pharmacy 23: 283–292 (1966).
Malcolm, R. and Miller, W.C.: Dimenhydrinate (Dramamine) abuse: Hallucinogenic experiences with a proprietary antihistamine. American Journal of Psychiatry 128: 1012–1013 (1972).
Malt, U.: Lithium carbonate and tetracycline interaction. British Medical Journal 2: 502 (1978).
Mann, A.M. and Hutchison, J.L.: Manic reaction associated with procarbazide hydrochloride therapy of Hodgkin’s disease. Canadian Medical Association Journal 97: 1350–1353 (1967).
Mann, J.; Branton, L.J. and Larkins, R.G.: Hyperosmolality complicating recovery from lithium toxicity. British Medical Journal 1: 1522–1523 (1978).
Matthew, H.: Acute poisoning: some myths and misconceptions. British Medical Journal 1: 519–522 (1971).
Matthew, H.: Are there safer hypnotics than barbiturates. Lancet 1: 224 (1974).
Matthew, H. and Lawson, A.A.H.: Treatment of Common Acute Poisonings, 3rd Ed (Churchill Livingstone, Edinburgh 1975).
Master, A.B.: Delayed death in imipramine poisoning. British Medical Journal 3: 866–867 (1967).
Meek, D.; Bort, M.H.; Mamtora, H. and Gabriel, R.: Convulsions following maprotiline overdose. British Medical Journal 2: 275 (1975).
Melmon, K.L.: Preventable drug reactions; causes and cures. New England Journal of Medicine 284: 1361–1368 (1971).
Miller, R.R.: Propoxyphene: A review. Journal of the Maine Medical Association 6: 4 (1977).
Mintz, U.; Liberman, U.A. and Vries, A. de: Parkinsonism syndrome due to cephaloridine. Journal of the American Medical Association 216: 1200 (1971).
Moskovitz, C.; Moses, R. and Klawans, H.L.: Levodopa-induced psychosis: A kindling phenomenon. American Journal of Psychiatry 135: 669–675 (1978).
Muniz, C.; Forman, A.J.; Wilder, B.J. and Ramsay, R.E.: Lithium toxicity with low serum levels: Report of a case. Clinical Electroencephalography 7: 31–34 (1976).
Murdoch, J.M.; Spiers, C.F.; Geddes, A.M. and Wallace, E.T.: Clinical trial of cephaloridine (ceporin) a new broad-spectrum antibiotic derived from cephalosporin c. British Medical Journal 2: 1238–1240 (1964).
Murray, G.: Toxic paranoid reaction to cephalothin. Drug Intelligence and Clinical Pharmacy 8: 71 (1974).
Mykyta, L.J.: A case of sulthiame overdosage. Medical Journal of Australia 11: 118 (1968).
Naylor, G.J. and McHarg, A.: Profound hypothermia on combined lithium carbonate and diazepam treatment. British Medical Journal 3: 22 (1977).
Neff, T.A.: Isoniazid toxicity: reports of lactic acidosis and keratitis. Chest 59: 245–248 (1971).
Newman, B. and Crome, P.: The clinical toxicity of mianserin hydrochloride. Abstract of paper presented at the meeting for the British Society for Toxicology (1978).
Nigro, S.A.: Toxic psychosis due to diphenhydramine hydrochloride (Benadryl). Journal of the American Medical Association 203: 301 (1968).
Noble, J. and Matthew, H.: Acute poisoning by tricyclic antidepressants. Clinical Toxicology 2: 403–421 (1969).
Nuki, G.; Richardson, P.; Goggin, M.J. and Bayliss, R.I.S.: Four cases of bromism. British Medical Journal 2: 390–391 (1966).
O’Brien, C.P.; Digiacoma, J.N.; Fahn, S. and Schwarz, G.A.: Mental effects of high dosage levodopa. Archives of General Psychiatry 24: 61–64 (1971).
Ogilvie, R.I. and Ruedy, J.: Adverse drug reactions during hospitalization. Canadian Medical Association Journal 97: 1450–1457 (1967).
Pandit, S.K.; Heisterkamp, D.A. and Cohen, P.J.: Further studies of the effects of lorazepam on recall. A dose-time-effect relationship. Anaesthesiology 49: 495–500 (1976).
Park, J. and Proudfoot, A.T.: Acute poisoning with maprotiline hydrochloride. British Medical Journal 2: 1573 (1977).
Pearlman, C.A. Jr.: Manic behavior and levodopa. New England Journal of Medicine 285: 1326 (1971).
Petursson, J.: Diethylpropion and paranoid psychosis. Australian and New Zealand Journal of Psychiatry 13: 67–68 (1979).
Pinder, R.M.; Brogden, R.N.; Sawyer, P.R.; Speight, T.M. and Avery, G.S.: Metoclopramide: A review of its pharmacoloical properties and clinical use. Drugs 12: 81–131 (1976).
Pinder, R.M.; Brodgen, R.N.; Speight, T.M. and Avery, G.S.: Sodium valproate: A review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs 13: 81–123 (1977).
Pinder, R.M.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Maprotiline: A review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs 13: 321–352 (1977).
Porteous, H.B. and Ross, D.N.: Mental symptoms in parkinsonism following benzhexol hydrochloride therapy. British Medical Journal 2: 138 (1956).
Porter, L.K.: Digitalis toxicity. Drug Intelligence and Clinical Pharmacy 8: 700–708 (1974).
Postma, J.U. and van Tilberg, W.: Visual hallucinations and delirium during treatment with amantadine (Symmetrel). Journal of the American Geriatrics Society 23: 212–215 (1975).
Proudfoot, A.T. and Park, J.: Changing patterns of drugs used for self-poisoning. British Medical Journal 1: 90–93 (1978).
Pugh, D.L.; McLaren, R.G; Edwards, G.F. and Jones, E.R.: Toxic psychiatric manifestations in the treatment of tuberculosis with sodium para-aminosalicylate. Tubercle 33: 369 (1952).
Rainey, J.M. and Crowder, M.K.: Prolonged psychosis attributed to phencyclidine: Report of three cases. American Journal of Psychiatry 132: 1076–1078 (1975).
Reid, D.D. and Kerr, W.C: Phenelzine poisoning responding to phenothiazine. Medical Journal of Australia 1214–1215 (1969).
Rifkin, A.; Quitkin, F. and Klein, D.F.: Organic brain syndrome during lithium carbonate treatment. Comprehensive Psychiatry 14: 251–254 (1973).
Riley, I.D.: Lomotil poisoning. Lancet 1: 373 (1969).
Ross, M.S.: Acute psychotic reactions to aqueous procaine penicillin G. Archives of Dermatology 106: 599 (1972).
Ross, R.R.: Use of pyridoxine hydrochloride to prevent isoniazid toxicity. Journal of the American Medical Association 168: 273 (1958).
Roth, M. and Myers, D.H.: The diagnosis of dementia; in Silverstone and Barraclough (Eds) pp.87–100 (Headley Brothers, Ashford 1978).
Ryback, R.S. and Schwab, R.S.: Manic response to levodopa therapy: Report of a case. New England Journal of Medicine 285: 788–789 (1971).
Sachs, B.A.: The toxicity of benadryl: Report of a case and a review of the literature. Annals of Internal Medicine 29: 135 (1948).
Saker, B.M.; Musk, A.W.; Haywood, E.F. and Hurst, P.E.: Reversible toxic psychosis after cephalexin. Medical Journal of Australia 1: 497 (1973).
Sayad, A.J.: Mania and bromism: A case report and a look to the future. American Journal of Psychiatry 133: 228–229 (1976).
Scharbach, H.: Complications psychiques des neuroleptiques etats confusoonirique. L’encephale 4: 163–171 (1978).
Schou, M.: Baastrup, P.C.; Grof, P.; Weis, P. and Angst, J.: Pharmacological and clinical problems of lithium prophylaxis. British Journal of Psychiatry 116: 615–619 (1970).
Schwartz, M.S. and Scott, D.F.: Aminophylline — induced seizures. Epilepsia 15: 501–505 (1974).
Serby, M.; Angrist, B. and Lieberman, A.: Mental disturbances during bromocriptine and lergotrile treatment of Parkinson’s disease. American Journal of Psychiatry 135: 1227–1229 (1978).
Shader, R.I. and Greenblatt, D.J.: Belladonna alkaloids and synthetic anticholinergics: Uses and toxicity; in Shader (Ed) Psychiatric Complications of Medical Drugs (Raven Press, New York 1972).
Shanahan, F.L.J, and Counihan, T.B.: Atenolol self-poisoning. British Medical Journal 2: 773 (1978).
Shannon, P.J.; Leonard, D. and Kidson, M.A.: Fenfluramine and psychosis. British Medical Journal 2: 576 (1974).
Shanson, B.: Amphetamine poisoning. British Medical Journal 1: 576 (1956).
Shear, M.K. and Sacks, M.: Digitalis delirium: Psychiatric considerations. International Journal of Psychiatry in Medicine 8: 371–381 (1977–1978).
Sheeny, M.L. and Maxmen, J.S.: Phenelzine-induced psychosis. American Journal of Psychiatry 135: 1422–1423 (1978).
Shepherd, G.A.A. and Kerr, F.: Maprotiline hydrochloride and grand-mal seizures. British Medical Journal 1: 1523 (1978).
Shopsin, B.; Johnson, G. and Gershon, S.: Neurotoxicity with lithium: Differential drug responsiveness. International Pharmacopsychiatry 5: 170 (1970).
Simpson, G.M.; Varga, E. and Haher, E.J.: Psychotic exacerbations produced by hemoleptics. Diseases of the Nervous System 37: 367–369 (1976).
Skausig, O.B. and Korsgaard, S.: Hallucinations and baclofen. Lancet 1: 1258 (1977).
Slater, E. and Roth, M.: Clinical Psychiatry 3rd ed (Bailliere, Tindall and Cassell, London 1969).
Smiler, B.G.; Bartholemen, E.G.; Sivak, B.J.; Alexander, G.D. and Brown, E.M.: Physostigmine reversal of scopolamine delirium in obstetric patients. American Journal of Obstetrics and Gynaecology 116: 326 (1973).
Smith, J.S. and Davidson, K.: Changes in the pattern of admissions for attempted suicide in Newcastle-Upon-Tyne during the 1960’s. British Medical Journal 4: 412–415 (1971).
Smith, W.H.; Thurn, R.H. and Bromer, L.: Comparative evaluations of Rauwolfia whole root and reserpine. Clinical Pharmacology and Therapeutics 10: 338 (1969).
Speirs, J. and Hirsch, S.R.: Severe lithium toxicity with “normal” serum concentrations. British Medical Journal 1: 815–816 (1978).
Stanley, B. and Pal, N.R.: Fatal hyperpyrexia with phenelzine and imipramine. British Medical Journal 4: 101 (1964).
Steel, C.M.; O’Duffy, J. and Brown, S.S.: Clinical effects and treatment of imipramine and amitriptyline poisoning in children. British Medical Journal 3: 663 (1967).
Stein, R.: Hallucinations after sudden withdrawal of baclofen. Lancet 2: 1381 (1977).
Steinert, J. and Pugh, C.R.: Two patients with schizophrenic-like psychosis after treatment with beta-adrenergic blockers. British Medical Journal 1: 790 (1979).
Stengal, E.: The organic confusional state and the organic dementia. British Journal of Hospital Medicine, March: 719–724 (1969).
Stephen, S.A.: Unwanted effects of propranolol. American Journal of Cardiology 18: 463 (1966).
Stephens, D.A.: Psychotoxic effects of benzhexol. British Journal of Psychiatry 1 13: 213 (1967).
Sternberg, L.: Unusual side reaction of hysteria from Benadryl. Journal of Allergy 15: 417 (1947).
Stewart, R.B. and Cluff, L.E.: A review of medication errors and compliance in ambulant patients. Clinical Pharmacology and Therapeutics 13: 463 (1972).
Straythorne, J.M. and Nash, J.L.: Severe neurotoxicity despite “therapeutic” serum lithium levels. Diseases of the Nervous System 38: 107–111 (1977).
Taylor, D.C.: Alarming reaction to pethidine in patients on phenelzine. Lancet 2: 401 (1962).
Taylor, M.; Galloway, D.B.; Petrie, J.C; Davidson, J.F.; Gallon, S.C and Moir, D.C.: Psychomimetic effect of pentazocine and dihydrocodeine tartrate. British Medical Journal 2: 1198 (1978).
Thornton, W.E. and Pray, B.J.: Lithium intoxication. Canadian Psychiatric Association Journal 20: 281–283 (1975).
Tobin, J.M. and Lewis, N.D.C.: New psychotherapeutic agent, chlordiazepoxide. Journal of the American Medical Association 174: 1242–1249 (1960).
Tompsett, R.: Pseudoanaphylactic reactions to procaine penicillin G. Archives of Internal Medicine 120: 565–567 (1967).
Tonks, C.M.: Lithium intoxication induced by dieting and saunas. British Medical Journal 2: 1396–1397 (1977).
Truelove, S.C. and Witts, L.J.: Cortisone and corticotrophin in ulcerative colitis. British Medical Journal 1: 387 (1959).
Tyrer, J.H.; Eadie, M.J.; Sutherland, J.M. and Hooper, W.D.: Outbreak of anticonvulsant intoxication in an Australian city. British Medical Journal 4: 271–273 (1970).
Ullman, K.C.; Groh, R.H. and Wolff, F.W.: Treatment of scopolamine-induced delirium. Lancet 1: 252 (1970).
Van Woert, M.H.; Ambani, L.M. and Weintraub, M.I.: Manic behaviour and levodopa. New England Journal of Medicine 285: 1326 (1971).
Von Hartitzsch, B.; Hoenich, N.A.; Leigh, R.J.; Wickinson, R.; Frost, T.H.; Weddel, A. and Posen, G.A.: Permanent neurological sequelae despite haemodyalisis for lithium intoxication. British Medical Journal 4: 757–759 (1972).
Vincent, F.M.: Case report fatal theophylline-induced seizures. Postgraduate Medicine 63: 76–77 (1978).
Wade, O.L.: Pattern of drug-induced disease in the community. British Medical Bulletin 26: 240–244 (1970).
Waldman, S. and Peiner, L.: Toxic psychosis due to overdosage with prophenpyridamine (Trimeton). Journal of the American Medical Association 143: 1334–1335 (1950).
Wallach, M.B. and Gershon, S.: Psychiatric sequelae to tuberculosis chemotherapy; in Shader (Ed) Psychiatric Complications of Medical Drugs (Raven Press, New York 1972).
Walzer, R.S.; Kurland, M.L. and Braun, M.: Clinical trial of methaminodiazepoxide. American Journal of Psychiatry 117: 456–457 (1960).
Whitlock, F.A.: Suicide in Brisbane, 1956 to 1973: The drug death epidemic. Medical Journal of Australia 1: 737–743 (1975).
Whitlock, F.A. and Evans, L.E.J.: Drugs and depression. Drugs 15: 53–71 (1978).
Whitlock, F.A. and Fama, P.G.: Hyoscine poisoning in psychiatric practice. Medical Journal of Australia 2: 763–764 (1966).
Whitlock, F.A. and Nadorfi, M.I.: Diethylpropion and psychosis. Medical Journal of Australia 2: 1097 (1970).
Wilkinson, D.G.: Difficulty in stopping lithium prophylaxis? British Medical Journal 1: 235–236 (1979).
Wolff, H.G. and Curran, D.: Nature of delirium and allied states. Archives of Neurology and Psychiatry 33: 1175–1215 (1935).
Wood, A.J.J.; Moir, D.C.; Campbell, C.; Davidson, J.F.; Gallon, S.C. and Henney, E.: Medicines evaluation and monitoring group: Central nervous system effects of pentazocine. British Medical Journal 1: 305–307 (1974).
Wood, R.A.: Organic illness. British Medical Journal 1: 723–726 (1975).
Yapalater, A.R. and Rockwell, F.V.: Toxic psychosis due to prophenpyridamine (Trimeton). Journal of American Medical Association 143: 428–429 (1950).
Yorkston, N.J.; Zaki, S.A.; Malik, M.K.U.; Morrison, R.C. and Havard, C.W.H.: Propranolol in the control of schizophrenic symptoms. British Medical Journal 4: 633–635 (1974).
Zbinden, G.; Bagdon, R.E.; Keith, E.F.; Phillips, R.D. and Randall, L.O.: Experimental and clinical toxicology of chlordiazepoxide (Librium). Toxicology and Applied Pharmacology 3: 619–637 (1961).
Ziven, I. and Shalowitz, M.D.: Acute toxic reaction to prolonged glutethimide administration. New England Journal of Medicine 266: 496 (1962).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Evans, L. Psychological Effects Caused by Drugs in Overdose. Drugs 19, 220–242 (1980). https://doi.org/10.2165/00003495-198019030-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198019030-00005